Product Information
CLINDAMYCIN-BENZOYL PEROX 1-5% is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.5007 per GM under NDC 45802050702. Its NADAC has been published 570 times since Nov 4, 2015.
FDA first approved this application on Sep 21, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802050702
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202440FDA Approved
9/21/2015
TE Code
AB
On Market Since
9/22/2015
Price Statistics
The NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has been published 570 times since Nov 4, 2015, and over the history we have for it it has declined 91.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5007 per GM |
|---|---|
| All-time high | $6.1380 (Dec 16, 2015) |
| All-time low | $0.4212 (Nov 20, 2024) |
| 52-week high | $0.6611 |
| 52-week low | $0.4647 |
| Median price | $1.3689 |
| Average price | $2.0945 |
| Largest weekly change | +55.5% (Aug 21, 2024) |
| Weeks tracked | 570 |
| Tracking since | Nov 4, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin and benzoyl peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN-BENZOYL PEROX 1-5%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN-BENZOYL PEROX 1-5%, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.5007 per GM (NDC 45802050702), effective Sep 30, 2026.
How has the price of CLINDAMYCIN-BENZOYL PEROX 1-5% changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has declined 91.8%. It has been tracked across 570 weekly CMS publications since Nov 4, 2015.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN-BENZOYL PEROX 1-5%?
Since Nov 4, 2015, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has ranged from a low of $0.4212 (Nov 20, 2024) to a high of $6.1380 (Dec 16, 2015), with a median of $1.3689 per GM.
Are there cheaper alternatives to CLINDAMYCIN-BENZOYL PEROX 1-5%?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN-BENZOYL PEROX 1-5% in a comparable dosage form, but none are currently priced below it.
Who manufactures CLINDAMYCIN-BENZOYL PEROX 1-5%?
CLINDAMYCIN-BENZOYL PEROX 1-5% (NDC 45802050702) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.